A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 study

Saved in:

Bibliographic Details
Published in:	Journal of hepatology Vol. 66; no. 1; pp. S101 - S102
Main Authors:	Koh, C, Surana, P, Han, T, Fryzek, N, Kapuria, D, Etzion, O, Takyar, V, Rotman, Y, Canales, R, Dahari, H, Yurdaydin, C, Glenn, J, Heller, T
Format:	Journal Article
Language:	English
Published:	2017
Subjects:	Gastroenterology and Hepatology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0168-8278
DOI:	10.1016/S0168-8278(17)30464-6